Jordanian Pharmaceutical Manufacturing reports Q3 profit of 277,136 dinars
Jordanian Pharmaceutical Manufacturing posted third-quarter net profit of 277,136 dinars on net sales of 4 million dinars, according to Reuters.
- published on Newsmetry
- original source published
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner. connect the api →
what happened
Jordanian Pharmaceutical Manufacturing (JPHM.AM) reported third-quarter net profit of 277,136 dinars. Net sales for the quarter came to 4 million dinars.
The information was published by Reuters. The report includes no comparison with earlier periods and no management commentary.
why it matters
This is a small company reporting results on a local market, so the impact on broader markets is limited. Investors in JPHM.AM shares should note that the figures cover only the quarter with no outlook provided.
tags
instruments
sources
- Jordanian Pharmaceutical Manufacturing Q3 Profit 277,136 Dinars — Reuters, 27 October 2026 at 06:54 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner.
get stories in real time ↗